Using LPS/ATP-induced RAW264.7 cells and DSS-induced colitis in mice, CGA was shown to reduce NLRP3 inflammasome-related proteins and miR-155 expression, suggesting a potential therapeutic strategy for UC (199). Here, NLRP3 is linked to colitis.